GRI Bio (GRI) Non-Current Assets (2020 - 2026)
GRI Bio (GRI) posted quarterly Non-Current Assets of $60000.0 for Q1 2026, down 46.43% year-over-year from $112000.0 in Q1 2025, and down 18.92% quarter-over-quarter from $74000.0 in Q4 2025.
GRI Bio (GRI) Non-Current Assets (2020 - 2026) Analysis & Trends
GRI Bio's Non-Current Assets history runs 7 years deep, the most recent figure standing at $60000.0 for Q1 2026.
- In Q1 2026, Non-Current Assets fell 46.43% year-over-year to $60000.0; the TTM figure through Mar 2026 stood at $318000.0 (down 38.73% YoY), while the FY2025 annual figure was $74000.0, down 40.32% from the prior year.
- Non-Current Assets for Q1 2026 stood at $60000.0, down from $74000.0 in the prior quarter.
- The five-year high for Non-Current Assets was $187000.0 in Q1 2022, with the low at $22000.0 in Q4 2023.
- The 5-year median for Non-Current Assets is $99000.0 (2025), against an average of $102133.3.
- The sharpest annual moves came in 2023 and 2024: Non-Current Assets tumbled 70.41% in 2023, then surged 463.64% in 2024.
- GRI Bio's Non-Current Assets stood at $71000.0 in 2022, then sank by 69.01% to $22000.0 in 2023, then soared by 463.64% to $124000.0 in 2024, then sank by 40.32% to $74000.0 in 2025, then fell by 18.92% to $60000.0 in 2026.
- Business Quant data shows GRI's Non-Current Assets at $60000.0 in Q1 2026, $74000.0 in Q4 2025, and $85000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 938.60 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 468.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 18.06 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 6.80 Bn |
| 10 | GRI Bio | 3.07 Mn | 3.07 Mn | - | 46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 74,000.00 |
| Sep 30, 2025 | 85,000.00 |
| Jun 30, 2025 | 99,000.00 |
| Mar 31, 2025 | 112,000.00 |
| Dec 31, 2024 | 124,000.00 |
| Sep 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 147,000.00 |
| Mar 31, 2024 | 159,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Jun 30, 2022 | 169,000.00 |
| Mar 31, 2022 | 187,000.00 |
| Dec 31, 2021 | 206,000.00 |
| Sep 30, 2021 | 224,000.00 |
| Jun 30, 2021 | 243,000.00 |
| Mar 31, 2021 | 262,000.00 |
| Dec 31, 2020 | 281,000.00 |